Sylhet Pharmacy LLC

Sylhet Pharmacy LLC was paid $949K by Medicaid between Dec 2021 and Aug 2022, across 11 billing codes. Its largest line is 87635, Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe — 52% of everything it billed.

33Billing provider infoSYLHET PHARMACY LLC
OZONE PARK, NY 11416

33aNPI1336543610assigned 10/15/2014

33bProvider typePharmacy

28Total paid$949K

24GClaims48,096

24DCodes billed11

24AFirst – last monthDec 2021 – Aug 2022

Compared with peers

Next to other Pharmacy providers in New York

Rank by total paid#10 of 126

Median peer was paid$2K

This provider vs. median403×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2021	11,158	$215K
2022	36,938	$734K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	52%	11,737	10,917	$492K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	37%	10,147	9,052	$355K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	7.3%	14,725	12,267	$70K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	2.6%	651	650	$25K
U0001	Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel	<1%	434	429	$3K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	6,275	5,561	$3K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	3,760	2,807	$969.49
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	25	25	$660.02
99441		<1%	71	71	$432.48
99072		0%	14	14	$0.00
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	0%	257	248	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCHOWDHURY, TASMINA (PRESIDENT)